nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—osteoarthritis—Methylprednisolone—multiple sclerosis	0.324	0.5	CpDpCtD
Oxaprozin—osteoarthritis—Prednisone—multiple sclerosis	0.324	0.5	CpDpCtD
Oxaprozin—PTGS2—Triamcinolone—multiple sclerosis	0.0906	0.396	CbGbCtD
Oxaprozin—PTGS2—Betamethasone—multiple sclerosis	0.0778	0.34	CbGbCtD
Oxaprozin—PTGS2—Dexamethasone—multiple sclerosis	0.0452	0.198	CbGbCtD
Oxaprozin—CYP2C9—Dexamethasone—multiple sclerosis	0.0154	0.0671	CbGbCtD
Oxaprozin—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000558	0.159	CbGdCrCtD
Oxaprozin—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000549	0.156	CbGdCrCtD
Oxaprozin—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000549	0.156	CbGdCrCtD
Oxaprozin—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000537	0.153	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000337	0.0958	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000332	0.0943	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000332	0.0943	CbGdCrCtD
Oxaprozin—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000324	0.0921	CbGdCrCtD
Oxaprozin—Oedema—Prednisolone—multiple sclerosis	0.000139	0.00117	CcSEcCtD
Oxaprozin—Dysuria—Methotrexate—multiple sclerosis	0.000139	0.00117	CcSEcCtD
Oxaprozin—Dizziness—Azathioprine—multiple sclerosis	0.000139	0.00116	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000139	0.00116	CcSEcCtD
Oxaprozin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000138	0.00116	CcSEcCtD
Oxaprozin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000138	0.00115	CcSEcCtD
Oxaprozin—Shock—Prednisolone—multiple sclerosis	0.000137	0.00115	CcSEcCtD
Oxaprozin—Convulsion—Triamcinolone—multiple sclerosis	0.000136	0.00114	CcSEcCtD
Oxaprozin—Tachycardia—Prednisolone—multiple sclerosis	0.000136	0.00114	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000136	0.00114	CcSEcCtD
Oxaprozin—Convulsion—Methylprednisolone—multiple sclerosis	0.000136	0.00114	CcSEcCtD
Oxaprozin—Hypertension—Triamcinolone—multiple sclerosis	0.000136	0.00114	CcSEcCtD
Oxaprozin—Hypertension—Methylprednisolone—multiple sclerosis	0.000135	0.00113	CcSEcCtD
Oxaprozin—Urticaria—Mitoxantrone—multiple sclerosis	0.000135	0.00113	CcSEcCtD
Oxaprozin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000135	0.00113	CcSEcCtD
Oxaprozin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000134	0.00112	CcSEcCtD
Oxaprozin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000134	0.00112	CcSEcCtD
Oxaprozin—Vomiting—Azathioprine—multiple sclerosis	0.000134	0.00112	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—multiple sclerosis	0.000134	0.00112	CcSEcCtD
Oxaprozin—Anxiety—Methylprednisolone—multiple sclerosis	0.000133	0.00111	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—multiple sclerosis	0.000133	0.00111	CcSEcCtD
Oxaprozin—Rash—Azathioprine—multiple sclerosis	0.000133	0.00111	CcSEcCtD
Oxaprozin—Dermatitis—Azathioprine—multiple sclerosis	0.000132	0.00111	CcSEcCtD
Oxaprozin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000132	0.00111	CcSEcCtD
Oxaprozin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000132	0.00111	CcSEcCtD
Oxaprozin—Discomfort—Triamcinolone—multiple sclerosis	0.000132	0.00111	CcSEcCtD
Oxaprozin—Discomfort—Methylprednisolone—multiple sclerosis	0.000132	0.0011	CcSEcCtD
Oxaprozin—Headache—Azathioprine—multiple sclerosis	0.000132	0.0011	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000132	0.0011	CcSEcCtD
Oxaprozin—Dry mouth—Triamcinolone—multiple sclerosis	0.000131	0.0011	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—multiple sclerosis	0.000131	0.00109	CcSEcCtD
Oxaprozin—Angioedema—Dexamethasone—multiple sclerosis	0.00013	0.00109	CcSEcCtD
Oxaprozin—Angioedema—Betamethasone—multiple sclerosis	0.00013	0.00109	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Oxaprozin—Confusional state—Methylprednisolone—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Oxaprozin—Malaise—Betamethasone—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Oxaprozin—Malaise—Dexamethasone—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Oxaprozin—Oedema—Triamcinolone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Vertigo—Dexamethasone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Vertigo—Betamethasone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Syncope—Betamethasone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Syncope—Dexamethasone—multiple sclerosis	0.000128	0.00107	CcSEcCtD
Oxaprozin—Arrhythmia—Prednisone—multiple sclerosis	0.000127	0.00107	CcSEcCtD
Oxaprozin—Infection—Triamcinolone—multiple sclerosis	0.000127	0.00107	CcSEcCtD
Oxaprozin—Infection—Methylprednisolone—multiple sclerosis	0.000127	0.00106	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—multiple sclerosis	0.000127	0.00106	CcSEcCtD
Oxaprozin—Shock—Triamcinolone—multiple sclerosis	0.000126	0.00106	CcSEcCtD
Oxaprozin—Insomnia—Prednisolone—multiple sclerosis	0.000126	0.00106	CcSEcCtD
Oxaprozin—Alopecia—Prednisone—multiple sclerosis	0.000126	0.00106	CcSEcCtD
Oxaprozin—Shock—Methylprednisolone—multiple sclerosis	0.000126	0.00105	CcSEcCtD
Oxaprozin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Paraesthesia—Prednisolone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Tachycardia—Triamcinolone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Nausea—Azathioprine—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Oxaprozin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Oxaprozin—Convulsion—Betamethasone—multiple sclerosis	0.000124	0.00103	CcSEcCtD
Oxaprozin—Convulsion—Dexamethasone—multiple sclerosis	0.000124	0.00103	CcSEcCtD
Oxaprozin—Hypertension—Dexamethasone—multiple sclerosis	0.000123	0.00103	CcSEcCtD
Oxaprozin—Hypertension—Betamethasone—multiple sclerosis	0.000123	0.00103	CcSEcCtD
Oxaprozin—Asthenia—Mitoxantrone—multiple sclerosis	0.000122	0.00102	CcSEcCtD
Oxaprozin—Anxiety—Betamethasone—multiple sclerosis	0.000121	0.00101	CcSEcCtD
Oxaprozin—Anxiety—Dexamethasone—multiple sclerosis	0.000121	0.00101	CcSEcCtD
Oxaprozin—Discomfort—Betamethasone—multiple sclerosis	0.00012	0.001	CcSEcCtD
Oxaprozin—Discomfort—Dexamethasone—multiple sclerosis	0.00012	0.001	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—multiple sclerosis	0.00012	0.001	CcSEcCtD
Oxaprozin—Hypotension—Methylprednisolone—multiple sclerosis	0.00012	0.001	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—multiple sclerosis	0.000119	0.000998	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—multiple sclerosis	0.000119	0.000998	CcSEcCtD
Oxaprozin—Vision blurred—Prednisone—multiple sclerosis	0.000117	0.00098	CcSEcCtD
Oxaprozin—Oedema—Betamethasone—multiple sclerosis	0.000116	0.000974	CcSEcCtD
Oxaprozin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000116	0.000974	CcSEcCtD
Oxaprozin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000116	0.000974	CcSEcCtD
Oxaprozin—Oedema—Dexamethasone—multiple sclerosis	0.000116	0.000974	CcSEcCtD
Oxaprozin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000116	0.000974	CcSEcCtD
Oxaprozin—Insomnia—Triamcinolone—multiple sclerosis	0.000116	0.000971	CcSEcCtD
Oxaprozin—Insomnia—Methylprednisolone—multiple sclerosis	0.000116	0.000969	CcSEcCtD
Oxaprozin—Infection—Betamethasone—multiple sclerosis	0.000116	0.000968	CcSEcCtD
Oxaprozin—Infection—Dexamethasone—multiple sclerosis	0.000116	0.000968	CcSEcCtD
Oxaprozin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000115	0.000964	CcSEcCtD
Oxaprozin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000115	0.000964	CcSEcCtD
Oxaprozin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000115	0.000962	CcSEcCtD
Oxaprozin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000115	0.000962	CcSEcCtD
Oxaprozin—Anaemia—Prednisone—multiple sclerosis	0.000115	0.000961	CcSEcCtD
Oxaprozin—Shock—Dexamethasone—multiple sclerosis	0.000114	0.000958	CcSEcCtD
Oxaprozin—Shock—Betamethasone—multiple sclerosis	0.000114	0.000958	CcSEcCtD
Oxaprozin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000114	0.000957	CcSEcCtD
Oxaprozin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000114	0.000954	CcSEcCtD
Oxaprozin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000114	0.000954	CcSEcCtD
Oxaprozin—Tachycardia—Dexamethasone—multiple sclerosis	0.000114	0.000951	CcSEcCtD
Oxaprozin—Tachycardia—Betamethasone—multiple sclerosis	0.000114	0.000951	CcSEcCtD
Oxaprozin—Angioedema—Prednisone—multiple sclerosis	0.000113	0.00095	CcSEcCtD
Oxaprozin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000113	0.000945	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000113	0.000943	CcSEcCtD
Oxaprozin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000113	0.000943	CcSEcCtD
Oxaprozin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000112	0.000942	CcSEcCtD
Oxaprozin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000112	0.000942	CcSEcCtD
Oxaprozin—Malaise—Prednisone—multiple sclerosis	0.000112	0.000937	CcSEcCtD
Oxaprozin—Vertigo—Prednisone—multiple sclerosis	0.000112	0.000934	CcSEcCtD
Oxaprozin—Syncope—Prednisone—multiple sclerosis	0.000111	0.000932	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—multiple sclerosis	0.000111	0.00093	CcSEcCtD
Oxaprozin—Anorexia—Dexamethasone—multiple sclerosis	0.000111	0.000928	CcSEcCtD
Oxaprozin—Anorexia—Betamethasone—multiple sclerosis	0.000111	0.000928	CcSEcCtD
Oxaprozin—Urticaria—Prednisolone—multiple sclerosis	0.000111	0.000927	CcSEcCtD
Oxaprozin—Loss of consciousness—Prednisone—multiple sclerosis	0.000109	0.000913	CcSEcCtD
Oxaprozin—Hypotension—Betamethasone—multiple sclerosis	0.000109	0.00091	CcSEcCtD
Oxaprozin—Hypotension—Dexamethasone—multiple sclerosis	0.000109	0.00091	CcSEcCtD
Oxaprozin—Vomiting—Mitoxantrone—multiple sclerosis	0.000108	0.000905	CcSEcCtD
Oxaprozin—Convulsion—Prednisone—multiple sclerosis	0.000108	0.000901	CcSEcCtD
Oxaprozin—Hypertension—Prednisone—multiple sclerosis	0.000107	0.000897	CcSEcCtD
Oxaprozin—Rash—Mitoxantrone—multiple sclerosis	0.000107	0.000897	CcSEcCtD
Oxaprozin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000107	0.000896	CcSEcCtD
Oxaprozin—Headache—Mitoxantrone—multiple sclerosis	0.000106	0.000891	CcSEcCtD
Oxaprozin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000106	0.000885	CcSEcCtD
Oxaprozin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000105	0.000883	CcSEcCtD
Oxaprozin—Anxiety—Prednisone—multiple sclerosis	0.000105	0.000882	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—multiple sclerosis	0.000105	0.000882	CcSEcCtD
Oxaprozin—Insomnia—Dexamethasone—multiple sclerosis	0.000105	0.000881	CcSEcCtD
Oxaprozin—Insomnia—Betamethasone—multiple sclerosis	0.000105	0.000881	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000105	0.000876	CcSEcCtD
Oxaprozin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000104	0.000875	CcSEcCtD
Oxaprozin—Paraesthesia—Betamethasone—multiple sclerosis	0.000104	0.000875	CcSEcCtD
Oxaprozin—Discomfort—Prednisone—multiple sclerosis	0.000104	0.000874	CcSEcCtD
Oxaprozin—Dyspepsia—Betamethasone—multiple sclerosis	0.000102	0.000857	CcSEcCtD
Oxaprozin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000102	0.000857	CcSEcCtD
Oxaprozin—Urticaria—Triamcinolone—multiple sclerosis	0.000102	0.000853	CcSEcCtD
Oxaprozin—Urticaria—Methylprednisolone—multiple sclerosis	0.000102	0.000851	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—multiple sclerosis	0.000102	0.000851	CcSEcCtD
Oxaprozin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000101	0.000849	CcSEcCtD
Oxaprozin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000101	0.000848	CcSEcCtD
Oxaprozin—Oedema—Prednisone—multiple sclerosis	0.000101	0.000848	CcSEcCtD
Oxaprozin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000101	0.000847	CcSEcCtD
Oxaprozin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000101	0.000847	CcSEcCtD
Oxaprozin—Decreased appetite—Betamethasone—multiple sclerosis	0.000101	0.000847	CcSEcCtD
Oxaprozin—Nausea—Mitoxantrone—multiple sclerosis	0.000101	0.000845	CcSEcCtD
Oxaprozin—Infection—Prednisone—multiple sclerosis	0.000101	0.000843	CcSEcCtD
Oxaprozin—Shock—Prednisone—multiple sclerosis	9.97e-05	0.000835	CcSEcCtD
Oxaprozin—Tachycardia—Prednisone—multiple sclerosis	9.89e-05	0.000828	CcSEcCtD
Oxaprozin—Hyperhidrosis—Prednisone—multiple sclerosis	9.79e-05	0.00082	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—multiple sclerosis	9.78e-05	0.000819	CcSEcCtD
Oxaprozin—Anorexia—Prednisone—multiple sclerosis	9.66e-05	0.000809	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—multiple sclerosis	9.63e-05	0.000806	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—multiple sclerosis	9.59e-05	0.000803	CcSEcCtD
Oxaprozin—Feeling abnormal—Betamethasone—multiple sclerosis	9.59e-05	0.000803	CcSEcCtD
Oxaprozin—Feeling abnormal—Dexamethasone—multiple sclerosis	9.59e-05	0.000803	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.51e-05	0.000796	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.51e-05	0.000796	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—multiple sclerosis	9.36e-05	0.000783	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—multiple sclerosis	9.32e-05	0.00078	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—multiple sclerosis	9.29e-05	0.000778	CcSEcCtD
Oxaprozin—Urticaria—Betamethasone—multiple sclerosis	9.24e-05	0.000774	CcSEcCtD
Oxaprozin—Urticaria—Dexamethasone—multiple sclerosis	9.24e-05	0.000774	CcSEcCtD
Oxaprozin—Dizziness—Prednisolone—multiple sclerosis	9.22e-05	0.000772	CcSEcCtD
Oxaprozin—Asthenia—Triamcinolone—multiple sclerosis	9.2e-05	0.00077	CcSEcCtD
Oxaprozin—Abdominal pain—Dexamethasone—multiple sclerosis	9.2e-05	0.00077	CcSEcCtD
Oxaprozin—Abdominal pain—Betamethasone—multiple sclerosis	9.2e-05	0.00077	CcSEcCtD
Oxaprozin—Body temperature increased—Betamethasone—multiple sclerosis	9.2e-05	0.00077	CcSEcCtD
Oxaprozin—Body temperature increased—Dexamethasone—multiple sclerosis	9.2e-05	0.00077	CcSEcCtD
Oxaprozin—Asthenia—Methylprednisolone—multiple sclerosis	9.18e-05	0.000768	CcSEcCtD
Oxaprozin—Insomnia—Prednisone—multiple sclerosis	9.16e-05	0.000767	CcSEcCtD
Oxaprozin—Paraesthesia—Prednisone—multiple sclerosis	9.1e-05	0.000762	CcSEcCtD
Oxaprozin—Pruritus—Triamcinolone—multiple sclerosis	9.07e-05	0.000759	CcSEcCtD
Oxaprozin—Pruritus—Methylprednisolone—multiple sclerosis	9.05e-05	0.000758	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—multiple sclerosis	8.99e-05	0.000753	CcSEcCtD
Oxaprozin—Dyspepsia—Prednisone—multiple sclerosis	8.92e-05	0.000747	CcSEcCtD
Oxaprozin—Decreased appetite—Prednisone—multiple sclerosis	8.81e-05	0.000737	CcSEcCtD
Oxaprozin—Rash—Prednisolone—multiple sclerosis	8.79e-05	0.000736	CcSEcCtD
Oxaprozin—Dermatitis—Prednisolone—multiple sclerosis	8.78e-05	0.000735	CcSEcCtD
Oxaprozin—Diarrhoea—Methylprednisolone—multiple sclerosis	8.75e-05	0.000733	CcSEcCtD
Oxaprozin—Headache—Prednisolone—multiple sclerosis	8.73e-05	0.000731	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—multiple sclerosis	8.73e-05	0.000731	CcSEcCtD
Oxaprozin—Constipation—Prednisone—multiple sclerosis	8.66e-05	0.000725	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—multiple sclerosis	8.54e-05	0.000715	CcSEcCtD
Oxaprozin—Dizziness—Triamcinolone—multiple sclerosis	8.48e-05	0.00071	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—multiple sclerosis	8.47e-05	0.000709	CcSEcCtD
Oxaprozin—Dizziness—Methylprednisolone—multiple sclerosis	8.46e-05	0.000708	CcSEcCtD
Oxaprozin—Infection—Methotrexate—multiple sclerosis	8.41e-05	0.000704	CcSEcCtD
Oxaprozin—Feeling abnormal—Prednisone—multiple sclerosis	8.35e-05	0.000699	CcSEcCtD
Oxaprozin—Asthenia—Betamethasone—multiple sclerosis	8.35e-05	0.000699	CcSEcCtD
Oxaprozin—Asthenia—Dexamethasone—multiple sclerosis	8.35e-05	0.000699	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—multiple sclerosis	8.29e-05	0.000694	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Prednisone—multiple sclerosis	8.28e-05	0.000694	CcSEcCtD
Oxaprozin—Nausea—Prednisolone—multiple sclerosis	8.28e-05	0.000693	CcSEcCtD
Oxaprozin—Pruritus—Betamethasone—multiple sclerosis	8.23e-05	0.000689	CcSEcCtD
Oxaprozin—Pruritus—Dexamethasone—multiple sclerosis	8.23e-05	0.000689	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—multiple sclerosis	8.19e-05	0.000685	CcSEcCtD
Oxaprozin—Vomiting—Triamcinolone—multiple sclerosis	8.15e-05	0.000683	CcSEcCtD
Oxaprozin—Vomiting—Methylprednisolone—multiple sclerosis	8.13e-05	0.000681	CcSEcCtD
Oxaprozin—Rash—Triamcinolone—multiple sclerosis	8.08e-05	0.000677	CcSEcCtD
Oxaprozin—Dermatitis—Triamcinolone—multiple sclerosis	8.08e-05	0.000676	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—multiple sclerosis	8.07e-05	0.000676	CcSEcCtD
Oxaprozin—Rash—Methylprednisolone—multiple sclerosis	8.07e-05	0.000675	CcSEcCtD
Oxaprozin—Dermatitis—Methylprednisolone—multiple sclerosis	8.06e-05	0.000675	CcSEcCtD
Oxaprozin—Urticaria—Prednisone—multiple sclerosis	8.05e-05	0.000674	CcSEcCtD
Oxaprozin—Headache—Triamcinolone—multiple sclerosis	8.03e-05	0.000672	CcSEcCtD
Oxaprozin—Headache—Methylprednisolone—multiple sclerosis	8.01e-05	0.000671	CcSEcCtD
Oxaprozin—Body temperature increased—Prednisone—multiple sclerosis	8.01e-05	0.000671	CcSEcCtD
Oxaprozin—Abdominal pain—Prednisone—multiple sclerosis	8.01e-05	0.000671	CcSEcCtD
Oxaprozin—Diarrhoea—Betamethasone—multiple sclerosis	7.96e-05	0.000666	CcSEcCtD
Oxaprozin—Diarrhoea—Dexamethasone—multiple sclerosis	7.96e-05	0.000666	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—multiple sclerosis	7.91e-05	0.000662	CcSEcCtD
Oxaprozin—Dizziness—Betamethasone—multiple sclerosis	7.69e-05	0.000644	CcSEcCtD
Oxaprozin—Dizziness—Dexamethasone—multiple sclerosis	7.69e-05	0.000644	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—multiple sclerosis	7.66e-05	0.000641	CcSEcCtD
Oxaprozin—Nausea—Triamcinolone—multiple sclerosis	7.62e-05	0.000638	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—multiple sclerosis	7.6e-05	0.000637	CcSEcCtD
Oxaprozin—Nausea—Methylprednisolone—multiple sclerosis	7.6e-05	0.000636	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—multiple sclerosis	7.55e-05	0.000632	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—multiple sclerosis	7.53e-05	0.00063	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—multiple sclerosis	7.45e-05	0.000624	CcSEcCtD
Oxaprozin—Vomiting—Betamethasone—multiple sclerosis	7.4e-05	0.000619	CcSEcCtD
Oxaprozin—Vomiting—Dexamethasone—multiple sclerosis	7.4e-05	0.000619	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—multiple sclerosis	7.36e-05	0.000616	CcSEcCtD
Oxaprozin—Rash—Dexamethasone—multiple sclerosis	7.34e-05	0.000614	CcSEcCtD
Oxaprozin—Rash—Betamethasone—multiple sclerosis	7.34e-05	0.000614	CcSEcCtD
Oxaprozin—Dermatitis—Betamethasone—multiple sclerosis	7.33e-05	0.000614	CcSEcCtD
Oxaprozin—Dermatitis—Dexamethasone—multiple sclerosis	7.33e-05	0.000614	CcSEcCtD
Oxaprozin—Headache—Betamethasone—multiple sclerosis	7.29e-05	0.00061	CcSEcCtD
Oxaprozin—Headache—Dexamethasone—multiple sclerosis	7.29e-05	0.00061	CcSEcCtD
Oxaprozin—Asthenia—Prednisone—multiple sclerosis	7.27e-05	0.000609	CcSEcCtD
Oxaprozin—Pruritus—Prednisone—multiple sclerosis	7.17e-05	0.0006	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—multiple sclerosis	6.98e-05	0.000584	CcSEcCtD
Oxaprozin—Diarrhoea—Prednisone—multiple sclerosis	6.93e-05	0.00058	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.92e-05	0.00058	CcSEcCtD
Oxaprozin—Nausea—Dexamethasone—multiple sclerosis	6.91e-05	0.000579	CcSEcCtD
Oxaprozin—Nausea—Betamethasone—multiple sclerosis	6.91e-05	0.000579	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—multiple sclerosis	6.73e-05	0.000563	CcSEcCtD
Oxaprozin—Dizziness—Prednisone—multiple sclerosis	6.7e-05	0.000561	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—multiple sclerosis	6.69e-05	0.00056	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—multiple sclerosis	6.69e-05	0.00056	CcSEcCtD
Oxaprozin—Vomiting—Prednisone—multiple sclerosis	6.44e-05	0.000539	CcSEcCtD
Oxaprozin—Rash—Prednisone—multiple sclerosis	6.39e-05	0.000535	CcSEcCtD
Oxaprozin—Dermatitis—Prednisone—multiple sclerosis	6.38e-05	0.000534	CcSEcCtD
Oxaprozin—Headache—Prednisone—multiple sclerosis	6.35e-05	0.000531	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—multiple sclerosis	6.08e-05	0.000509	CcSEcCtD
Oxaprozin—Nausea—Prednisone—multiple sclerosis	6.02e-05	0.000504	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—multiple sclerosis	5.99e-05	0.000502	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—multiple sclerosis	5.79e-05	0.000485	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—multiple sclerosis	5.6e-05	0.000469	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—multiple sclerosis	5.38e-05	0.000451	CcSEcCtD
Oxaprozin—Rash—Methotrexate—multiple sclerosis	5.34e-05	0.000447	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—multiple sclerosis	5.33e-05	0.000447	CcSEcCtD
Oxaprozin—Headache—Methotrexate—multiple sclerosis	5.3e-05	0.000444	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—multiple sclerosis	5.03e-05	0.000421	CcSEcCtD
Oxaprozin—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	3.03e-05	0.0663	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	2.3e-05	0.0505	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	1.49e-05	0.0325	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	1.34e-05	0.0293	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	1.34e-05	0.0293	CbGpPWpGaD
Oxaprozin—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	1.34e-05	0.0293	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.31e-05	0.0287	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.31e-05	0.0287	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	1.09e-05	0.0239	CbGpPWpGaD
Oxaprozin—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	1.06e-05	0.0233	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	8.83e-06	0.0194	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.5e-06	0.0186	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.5e-06	0.0186	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.39e-06	0.0184	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.39e-06	0.0184	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	7.31e-06	0.016	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	7.11e-06	0.0156	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	6.96e-06	0.0153	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	6.96e-06	0.0153	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.89e-06	0.0151	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.89e-06	0.0151	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	6.51e-06	0.0143	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	6.35e-06	0.0139	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	6.08e-06	0.0133	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	4.91e-06	0.0108	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	4.82e-06	0.0105	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	4.73e-06	0.0104	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	4.6e-06	0.0101	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.38e-06	0.0096	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	4.3e-06	0.00942	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	4.21e-06	0.00923	CbGpPWpGaD
Oxaprozin—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	4.1e-06	0.00898	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	3.97e-06	0.00869	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	3.9e-06	0.00855	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.85e-06	0.00844	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	3.82e-06	0.00837	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	3.66e-06	0.00802	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	3.66e-06	0.00802	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.61e-06	0.00791	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.61e-06	0.00791	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	3.34e-06	0.00731	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	3.15e-06	0.0069	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.95e-06	0.00646	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.93e-06	0.00641	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	2.78e-06	0.00609	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	2.77e-06	0.00608	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.67e-06	0.00586	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.67e-06	0.00586	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.62e-06	0.00574	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	2.49e-06	0.00546	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	2.47e-06	0.00541	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	2.44e-06	0.00535	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.32e-06	0.00509	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	2.31e-06	0.00507	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.23e-06	0.00488	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.12e-06	0.00465	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.12e-06	0.00465	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.11e-06	0.00462	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.08e-06	0.00456	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.06e-06	0.00452	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.02e-06	0.00442	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.99e-06	0.00435	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	1.94e-06	0.00425	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.92e-06	0.00421	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	1.92e-06	0.0042	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.91e-06	0.00419	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	1.84e-06	0.00403	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	1.8e-06	0.00394	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	1.77e-06	0.00388	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.77e-06	0.00387	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.69e-06	0.00371	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SRM—multiple sclerosis	1.69e-06	0.0037	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	1.64e-06	0.0036	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.58e-06	0.00346	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—POMC—multiple sclerosis	1.57e-06	0.00343	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.55e-06	0.0034	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.45e-06	0.00318	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	1.44e-06	0.00316	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.41e-06	0.00308	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.41e-06	0.00308	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	1.4e-06	0.00306	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SRM—multiple sclerosis	1.34e-06	0.00294	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.28e-06	0.00279	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.25e-06	0.00273	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.24e-06	0.00272	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP24A1—multiple sclerosis	1.19e-06	0.00261	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP27B1—multiple sclerosis	1.19e-06	0.00261	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.18e-06	0.00258	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.16e-06	0.00255	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	1.16e-06	0.00255	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.14e-06	0.00251	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPC5—multiple sclerosis	1.09e-06	0.00239	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GPC5—multiple sclerosis	1.03e-06	0.00226	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	9.72e-07	0.00213	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	9.69e-07	0.00212	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	9.51e-07	0.00208	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP27B1—multiple sclerosis	9.45e-07	0.00207	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP24A1—multiple sclerosis	9.45e-07	0.00207	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.24e-07	0.00202	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	9.24e-07	0.00202	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	9.05e-07	0.00198	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RRM1—multiple sclerosis	9.02e-07	0.00198	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SRM—multiple sclerosis	8.89e-07	0.00195	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPC5—multiple sclerosis	8.65e-07	0.00189	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	8.23e-07	0.0018	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	7.3e-07	0.0016	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RRM1—multiple sclerosis	7.16e-07	0.00157	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7e-07	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL5—multiple sclerosis	6.71e-07	0.00147	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.61e-07	0.00145	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.59e-07	0.00144	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.47e-07	0.00142	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC11A1—multiple sclerosis	6.43e-07	0.00141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.26e-07	0.00137	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.26e-07	0.00137	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.16e-07	0.00135	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.12e-07	0.00134	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.01e-07	0.00132	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPC5—multiple sclerosis	5.73e-07	0.00125	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.56e-07	0.00122	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.48e-07	0.0012	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BCHE—multiple sclerosis	5.18e-07	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD28—multiple sclerosis	5.13e-07	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.77e-07	0.00105	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RRM1—multiple sclerosis	4.74e-07	0.00104	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.35e-07	0.000954	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BCHE—multiple sclerosis	4.11e-07	0.000901	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.68e-07	0.000806	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD86—multiple sclerosis	3.66e-07	0.000803	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CCR5—multiple sclerosis	3.25e-07	0.000712	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HLA-A—multiple sclerosis	3.17e-07	0.000694	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.16e-07	0.000693	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOE—multiple sclerosis	3.12e-07	0.000683	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOE—multiple sclerosis	2.96e-07	0.000648	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.88e-07	0.000632	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.72e-07	0.000597	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—multiple sclerosis	2.68e-07	0.000587	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD80—multiple sclerosis	2.67e-07	0.000585	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOE—multiple sclerosis	2.48e-07	0.000542	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—multiple sclerosis	2.44e-07	0.000535	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TYK2—multiple sclerosis	2.26e-07	0.000494	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—multiple sclerosis	2.13e-07	0.000466	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—multiple sclerosis	2.04e-07	0.000447	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—multiple sclerosis	1.94e-07	0.000425	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOE—multiple sclerosis	1.64e-07	0.000359	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—multiple sclerosis	1.58e-07	0.000346	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—multiple sclerosis	1.47e-07	0.000322	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—multiple sclerosis	1.46e-07	0.000321	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK1—multiple sclerosis	1.44e-07	0.000315	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—multiple sclerosis	1.41e-07	0.000309	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—multiple sclerosis	1.28e-07	0.000281	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—multiple sclerosis	1.1e-07	0.000242	CbGpPWpGaD
